Hong Kong pharmaceutical stocks strengthened, with CanSino Biologics rising nearly 6%.

As of the time of writing, Kanglong Huacheng is up 5.63%, WuXi AppTec is up 3.34%, and WuXi Biologics is up 3.04%.